Ocrelizumab website
  • Updated safety analysis
  • Safety topics
  • Post-marketing commitments
MedInfo FAQs Glossary Roche logo
  • Progressive multifocal leukoencephalopathy
  • Malignancies
  • Infections
  • COVID-19
  • Pregnancy and lactation
  • Serum Ig levels
  • Progressive multifocal leukoencephalopathy
  • Malignancies
  • Infections
  • COVID-19
  • Pregnancy and lactation
  • Serum Ig levels
Medical info request

Sitemap

Homepage
Updated safety analysis
Safety topics
Progressive multifocal leukoencephalopathy
Malignancies
Infections
COVID-19
Pregnancy and lactation
Serum Ig levels
Post-marketing commitments
FAQs
Glossary

Legal Statement
|
Privacy Policy
|
Sitemap
|
Cookies Settings
© F. Hoffmann La-Roche Ltd. |
This site is intended for healthcare professionals only, outside the US.
M-XX-00016074 (Date of preparation: January 2024)

To request a copy of your local ocrelizumab prescribing information, please click here

Link to third party site

The link you have selected will take you away from this site to one that is not owned or controlled by Roche, F. Hoffmann-La Roche Ltd makes no representation as to the accuracy of the information contained on sites we do not own or control. Roche does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Continue